Dow Jones 30 Stocks SEC Filings — May 21, 2026

21-05-2026

AvalonBay Communities and Equity Residential announced a definitive all-stock merger of equals, creating a combined company with a pro forma equity market capitalization of approximately $52 billion and enterprise value of $69 billion, encompassing over 180,000 rental apartments. The transaction is expected to generate $175 million in gross synergies and $125 million in net synergies, with AvalonBay shareholders receiving 2.793 shares of Equity Residential common stock per share, resulting in 51.2% ownership for AvalonBay and 48.8% for Equity Residential. However, the merger faces execution risks including shareholder approval requirements and integration challenges, and the combined company's initial annualized dividend of $2.81 per share is higher than AvalonBay's current yield but equivalent to Equity Residential's existing dividend.

• · Transaction expected to close in second half of 2026, subject to shareholder approvals and customary conditions.
• · Merger qualifies as a tax-free reorganization for U.S. federal income tax purposes.
• · Combined company will have dual headquarters in Arlington, VA and Chicago, IL, operating under a new name to be announced at closing.
• · Board of Trustees will consist of 7 existing trustees from Equity Residential and 7 existing directors from AvalonBay, with Steve Sterrett as Chairman.
• · Benjamin Schall will serve as President, CEO, and Trustee of the combined company; Mark J. Parrell will retire at closing.
• · Combined company has A3/A- credit ratings from Moody's and S&P respectively.
• · 30% of combined communities include affordable or mixed-income housing, representing about 7,200 affordable units.
• · Both companies intend to maintain regular quarterly dividends until transaction close.

21-05-2026

GlobalTech Corp reported Q1 2026 net revenue of $10.4 million, up from $4.3 million in Q1 2025, driven by the acquisition of a 51% stake in Moda in Pelle. However, GAAP net loss widened to $4.0 million from $1.1 million, and Adjusted EBITDA was negative $1.3 million versus negative $0.1 million in the prior year, reflecting higher operating costs and integration expenses.

• · The acquisition of 51% ownership in 123 Investments Limited (Moda in Pelle) closed on December 15, 2025.
• · Q1 2026 results include contributions from international termination, broadband, technology services, and retail footwear revenue streams.
• · GAAP net loss attributable to common shareholders was $2.1 million, or $(0.014) per basic and diluted share.
• · Depreciation and amortization increased to $1.909 million in Q1 2026 from $0.501 million in Q1 2025.
• · Finance cost rose to $0.801 million in Q1 2026 from $0.347 million in Q1 2025.
• · The company is preparing for a potential uplisting to the Nasdaq Capital Market, subject to regulatory review and meeting listing requirements.
• · Moda in Pelle operates retail, online, wholesale, and concession channels in the United Kingdom.
• · The company does not currently meet Nasdaq's initial listing requirements.

21-05-2026

Apple iSports Group, Inc. reported a net loss of $385,221 for Q1 2026, a significant improvement from the $3,191,732 loss in Q1 2025, driven by a sharp reduction in consulting and professional fees. However, the company still has zero revenue, its cash position collapsed from $55,938 to just $860, and total stockholders' deficit widened to $4,385,268 from $4,061,454, indicating severe liquidity constraints.

• · Zero net revenues for both Q1 2026 and Q1 2025.
• · Total current liabilities of $6,776,777 exceed total assets of $2,391,509, resulting in negative working capital.
• · Accumulated deficit increased to $20,051,879 from $19,666,658.
• · Foreign currency translation adjustment loss of $188,593 in Q1 2026 vs $10,731 in Q1 2025.
• · Related party loans payable increased to $2,430,764 from $2,261,484.
• · Deferred financing costs (current and non-current) total $2,295,042, representing a significant asset relative to cash.
• · Stock options outstanding increased from 8,275,000 to 9,275,000 (Series 2) during Q1 2026.
• · Intrinsic value of outstanding options declined from $3,144,500 to $1,670,428 (Series 2) and from $760,000 to $360,200 (Series 1).

21-05-2026

SpringBig Holdings, Inc. disclosed that on May 15, 2026, lead noteholders Shalcor Management, Inc. and Lightbank II, L.P. suspended the company's voting and consensual rights over its operating subsidiary, SpringBig Inc., and vested those rights in Shalcor as collateral agent. As a result, CEO Jaret Christopher was removed from both CEO and director roles at the operating subsidiary, with Coley Brown appointed interim CEO and Ivona Smith as a director. The noteholders have not accelerated or demanded principal repayment, but the company has limited access to financial resources to continue operations.

• · The triggering event occurred on May 15, 2026, when lead noteholders sent a 'Notice of Suspension of Rights and Exercise of Rights with respect to Pledged Securities, and Reservation of Rights'.
• · The company had previously disclosed a default notice on April 28, 2026, regarding its 2024 Secured Term Notes and 2024 Secured Convertible Notes.
• · The noteholders have not yet accelerated or demanded any payment of principal, but the company has no assurance they will not enforce additional rights in the future.
• · The company is an emerging growth company and has elected not to use the extended transition period for complying with new or revised financial accounting standards.

21-05-2026

General Fusion Inc. appointed Thomas Boehlert to its Board of Directors, effective May 12, 2026, as Chair of the Nominating and Governance Committee, as the company advances toward its proposed business combination with Spring Valley Acquisition Corp. III (NASDAQ: SVAC). Boehlert brings over three decades of capital markets and leadership experience across industrials, natural resources, and energy transition sectors. The filing also highlights progress on General Fusion's LM26 fusion demonstration machine, which began operations in early 2025 and aims to achieve key technical milestones including the Lawson criterion.

• · Thomas Boehlert previously served as CFO of Bunge Limited, CFO of Kinross Gold, and CEO of First Nickel.
• · General Fusion was established in 2002 and is headquartered in Vancouver, Canada.
• · LM26 is the first MTF demonstration machine built at a commercially relevant scale, mechanically compressing plasma with a lithium liner at 50% commercial-scale diameter.
• · LM26 aims to achieve plasma heating to 1 keV (10 million degrees Celsius), then 10 keV (100 million degrees Celsius), and ultimately the Lawson criterion.
• · Spring Valley I completed a business combination with NuScale Power; Spring Valley II with Eagle Nuclear Energy Corp.
• · The business combination agreement was dated January 21, 2026, and involves SVAC continuing from Cayman Islands to British Columbia, an amalgamation, and a name change to 'General Fusion Group Ltd.'

21-05-2026

CTC Alternative Strategies, Ltd. reported its Q1 2026 institutional holdings in a 13F-HR filing, disclosing 96 equity positions with a total market value of approximately $44.0 million as of March 31, 2026. The portfolio is heavily concentrated in technology and financial sectors, with top holdings including Select Sector SPDRs (State Street), Coinbase Global, and ARM Holdings. The filing reflects a diversified mix of large-cap, mid-cap, and small-cap positions, with notable exposure to growth-oriented names such as NVIDIA, Tesla, and Snowflake.

• · The filing was submitted on May 21, 2026, for the period ending March 31, 2026.
• · All 96 positions are listed as sole voting and dispositive power, with no shared or non-voting holdings.
• · Top five holdings by market value: Select Sector SPDR (State Street) - $2,949,874 (26,609 shares), Coinbase Global - $2,693,010 (15,423 shares), ARM Holdings - $2,321,543 (15,346 shares), Broadcom - $1,927,628 (6,228 shares), and Select Sector SPDR (Consumer) - $1,926,439 (17,677 shares).
• · The portfolio includes a mix of large established companies (e.g., Berkshire Hathaway, JPMorgan Chase, Walmart) and speculative/small-cap names (e.g., Alt5 Sigma, Bitmine Immersion, Eightco Holdings).
• · Notable biotech holdings include C4 Therapeutics, Caribou Biosciences, ImmuniC, Invivyd, Lexicon Pharmaceuticals, Lineage Cell Therapeutics, Ocugen, Palisade Bio, Praxis Precision Medicines, and Zentalis Pharmaceuticals.
• · The filing was signed by Ethan Morgan, Senior Compliance Officer, on May 8, 2026.

21-05-2026

BankUnited, Inc. held its 2026 Annual Meeting on May 21, 2026, where shareholders approved the Amended and Restated 2023 Omnibus Equity Incentive Plan, increasing the share reserve by 1.5 million shares to a total of 2,301,549 shares and extending the plan termination date to May 21, 2036. All nine director nominees were elected, and the appointment of Deloitte & Touche LLP as independent auditor for 2026 was ratified. However, the advisory vote on executive compensation (Say-on-Pay) received only 89.5% support, and the equity plan approval was notably close, with 60.2% for and 39.8% against, indicating significant shareholder dissent.

• · The Amended Plan extends the termination date from May 16, 2033 to May 21, 2036.
• · The equity plan approval received 36,175,265 For votes, 23,906,092 Against, and 993,760 Abstain, with 6,891,801 broker non-votes.
• · The Say-on-Pay proposal received 54,673,360 For, 6,236,321 Against, and 165,436 Abstain, with 6,891,801 broker non-votes.
• · Auditor ratification was overwhelmingly approved with 67,952,223 For, 7,163 Against, and 7,532 Abstain.
• · All director nominees were elected with For votes ranging from 59,527,530 (Sanjiv Sobti) to 60,953,296 (John N. DiGiacomo).

21-05-2026

Veritone, Inc. entered into a Sales Agreement with UBS Securities LLC, Needham & Company, LLC, and Craig-Hallum Capital Group LLC to offer and sell up to $50.0 million of its common stock from time to time in at-the-market offerings. The Sales Agents will receive up to 3.0% of gross sales price as compensation, and the company is not obligated to sell any shares. The filing does not include any period-over-period financial comparisons, so no balanced performance analysis is possible.

• · The Sales Agreement was entered into on May 21, 2026.
• · The offering is made under an existing effective registration statement on Form S-3 (File No. 333-280148) effective June 21, 2024.
• · Sales may be made directly on The Nasdaq Global Market or any other trading market for the company's common stock.
• · The Sales Agents will use commercially reasonable efforts to sell shares based on company instructions.
• · The company will reimburse the Sales Agents for certain expenses and provide indemnification against certain liabilities.
• · The offering may terminate upon election of Sales Agents on adverse events, ten days' advance notice from either party, or mutual agreement.
• · No period-over-period financial data is included in this filing.

21-05-2026

Shoe Carnival reported mixed Q1 2026 results with net sales declining 2.5% YoY to $270.7M (from $277.7M) and GAAP net loss of $(5.6)M or $(0.21) per diluted share, driven by $13.6M in pretax charges for CEO transition and strategic review. However, adjusted EPS of $0.23 met consensus expectations, cash and marketable securities rose 39% to $129.3M, and the company remains debt-free. Both banners saw sales declines — Shoe Carnival down 2.2% (comparable sales -1.7%) and Shoe Station down 3.1% (comparable sales -2.9%) — though the Shoe Carnival banner's decline improved meaningfully from mid-to-high single-digit drops in Fiscal 2025.

• · Pretax charges totaled $13.6M ($5.3M CEO Transition + $8.3M strategic review including impairment of store locations and write-offs of rebanner-related and corporate fixed assets).
• · GAAP effective tax rate was (11.2)% vs 28.1% in prior year, impacted by $1.6M in nondeductible CEO severance payments.
• · Adjusted SG&A (non-GAAP) decreased $1.3M YoY after excluding the $13.6M non-recurring charges.
• · Cash flow from operations increased $32.7M and capital expenditures declined $2.9M in Q1 2026 vs Q1 2025.
• · Company expects inventory declines of $50M to $65M by end of Fiscal 2026 vs end of Fiscal 2025.
• · Fiscal 2026 guidance: Net sales $1.125B-$1.147B (flat YoY), Adjusted EPS $1.40-$1.60, gross profit margin ~34% (260 bps compression), adjusted SG&A reductions of $12M-$14M, adjusted tax rate ~26%.
• · Company ended Q1 2026 debt-free, marking 21st consecutive fiscal year with no debt.
• · Annual Shareholder Meeting scheduled for June 10, 2026 at 11:00 a.m. Eastern Time.
• · The Company's board completed a strategic review concluding to operate both Shoe Carnival and Shoe Station banners as permanent, independent portfolio components rather than rebannering all locations.

21-05-2026

Walmart reported strong Q1 FY27 results with revenue of $177.8B, up 7.3% (5.9% cc), and operating income growth of 5.0% (5.1% adjusted cc). eCommerce sales surged 26% globally and the advertising business grew 37%. However, free cash flow turned sharply negative at -$1.9B (down $2.4B from the prior year), and operating cash flow decreased $0.7B to $4.7B. GAAP EPS was $0.67 and adjusted EPS was $0.66. The company issued Q2 guidance (net sales +4-5% cc, adjusted op income +7-10% cc, adj. EPS $0.72-$0.74) and reiterated its full-year FY27 outlook unchanged.

• · Gross profit rate improved 6 bps, led by Walmart U.S.
• · Operating income negatively affected by 250 bps from higher fuel costs in distribution and fulfillment
• · ROA at 8.4%; ROI at 14.9%, negatively affected ~45 bps from discrete items
• · Walmart U.S. eCommerce contribution to comp sales ~530 bps, up from ~350 bps in prior year
• · Sam's Club eCommerce contribution to comp ~400 bps, up from ~350 bps in prior year
• · Walmart U.S. operating expense deleveraged 56 bps, reflecting higher depreciation and healthcare costs
• · Walmart International currency fluctuation positively affected sales by $2.3B and operating income by $0.2B
• · Sam's Club membership fee revenue grew 5.6% with steady growth in member counts, renewal rates, and Plus members
• · Walmart U.S. inventory increased 8.0% due to timing of receipts and inventory tied to accelerated unit volume in grocery
• · Sam's Club inventory increased 14.9%, primarily related to higher fuel costs/volumes including fuel upstreaming with a strategic partner
• · Company raised $4.25B in long-term debt for general corporate purposes at favorable rates

21-05-2026

Barinthus Biotherapeutics plc held a Court Meeting and General Meeting on May 20, 2026, where shareholders overwhelmingly approved the Scheme of Arrangement and the Scheme Implementation Proposal. At the Court Meeting, 99.98% of Scheme Shares voted in favor, and at the General Meeting, 99.98% of votes cast supported the special resolutions. The results are final, and the company is proceeding with the scheme transaction.

• · The Court Meeting had 0 broker non-votes and 0 abstentions.
• · The General Meeting had 10 abstentions and 0 broker non-votes.
• · The Scheme Implementation Proposal is described in detail in the proxy statement filed on April 22, 2026.

21-05-2026

VIDA Global Inc. announced the listing of its tokenized equity on xStocks via a press release on May 21, 2026. The filing is a Regulation FD disclosure and does not contain financial results or quantitative data.

• · The press release is furnished as Exhibit 99.1 and incorporated by reference.
• · The information is furnished, not filed, under the Exchange Act.

21-05-2026

Babcock & Wilcox Enterprises, Inc. filed an S-3 shelf registration statement to register securities for future offerings. The prospectus highlights a strong pipeline growth of 84% QoQ to over $14.0B (from $7.6B), 88% of LTM Q1 2026 revenue from aftermarket activity, and optimistic industry tailwinds from rising natural gas prices and supportive U.S. executive orders. However, the filing prominently warns of high investment risk, including potential volatility in the common stock price, reliance on a pipeline that may not convert to revenue, and exposure to customer capital expenditure cycles.

• · Global electricity demand expected to grow from 27,290 TWh (2024) to 37,819 TWh (2035) and 50,667 TWh (2050) per IEA.
• · U.S. federal government issued two executive orders supporting coal energy in 2025 and 2026.
• · The company targets BrightLoop small-scale deployment in 2027, medium-scale in 2029, and large-scale in 2032.
• · Pipeline may not generate margins equal to historical operating results and may fail to convert to revenue.
• · Common stock is listed on NYSE under symbol BW and is subject to significant price and volume fluctuations.

21-05-2026

NanoViricides, Inc. disclosed that its President and Executive Chairman, Dr. Anil R. Diwan, participated in the AGP Healthcare Companies Showcase on May 20, 2026, where he stated that the company's two drug candidates—NV-387 and NV-387 encapsulating Remdesivir—are expected to be effective against the current Ebola virus Bundibugyo strain in the DRC. The company has a clinical site in DRC for Mpox treatment, but no specific clinical data or timeline for Ebola was provided, and the efficacy of remdesivir against Ebola in prior human trials was not established.

• · NV-387 is a broad-spectrum antiviral entering Phase II clinical trial against Mpox in DRC.
• · NV-387 encapsulating Remdesivir is an oral formulation that protects remdesivir against bodily metabolism, as published in a peer-reviewed PLOS ONE paper.
• · Remdesivir's efficacy against Ebola was not established in prior human clinical trials, but safety and tolerability were confirmed.
• · The company has a clinical site in DRC for Mpox treatment.

21-05-2026

Barnwell Industries reported a net loss attributable to the company of $1.15M for Q2 FY2026 (three months ended March 31, 2026), narrowing from a $1.207M loss in the prior-year quarter. Revenue fell 29% to $2.535M, driven by a $1.06M decline in oil and natural gas sales. However, operating costs decreased 19% to $3.983M, and the company recorded a $338,000 equity in income of affiliates, partially offsetting the revenue drop. For the six-month period, the net loss attributable to Barnwell improved to $2.576M from $3.124M a year ago, though cash used in operations increased to $2.422M from $854M.

• · The company issued 926,403 shares of common stock, net of costs, during the six months ended March 31, 2026, raising $3.365M.
• · Cash used in operating activities from continuing operations increased to $2.422M in H1 FY2026 from $0.854M in H1 FY2025, a 184% increase.
• · Capital expenditures for oil and natural gas dropped sharply to $0.25M in H1 FY2026 from $2.641M in H1 FY2025.
• · The company recorded a $338,000 equity in income of affiliates in Q2 FY2026, compared to $0 in the prior-year quarter.
• · Accumulated deficit widened to $9.084M at March 31, 2026 from $6.508M at September 30, 2025.
• · Total liabilities decreased to $13.388M from $13.790M over the same period.
• · The company had no discontinued operations in FY2026; the prior-year period included a contract drilling segment that was sold.

21-05-2026

Multiple Puerto Rico closed-end funds are evaluating a strategic shift to an open-end fund structure via mergers, aiming to provide shareholders daily liquidity at NAV. The Board of each fund is conducting a thorough analysis of such mergers, which would require shareholder approval and SEC filings. However, the outcome remains uncertain—if shareholder approval is not obtained, the Board will explore other strategic alternatives to enhance liquidity.

• · The announement was made on May 20, 2026, from San Juan, Puerto Rico.
• · Each Fund is a Puerto Rico unlisted closed-end fund registered under the Investment Company Act of 1940.
• · The evaluation is being conducted by the Board of Directors of each Fund.
• · A merger would require a final analysis by the Board covering portfolio composition, liquidity, regulatory requirements, tax implications, regulatory approvals, and long-term viability of the surviving open-end fund.
• · If a merger is approved, the surviving open-end fund would file an SEC registration statement on Form N-14 including a proxy statement/prospectus.
• · If shareholder approval is not obtained, the Board intends to examine other strategic alternatives to provide enhanced liquidity at or as close to NAV as possible.
• · Contact information: Patricia Duque, telephone (787) 522-6776.

21-05-2026

Ivanhoe Electric Inc. disclosed that its majority-owned subsidiary Cordoba Minerals Corp. entered into a consulting agreement with Quentin Markin as interim CEO, effective May 20, 2026. Mr. Markin will receive a monthly fee of $7,500 plus expense reimbursement. The agreement terminates upon appointment of a new CEO or by notice. Mr. Markin continues as EVP of Business Development and Strategy Execution at Ivanhoe Electric and as a Cordoba Minerals director.

• · The consulting agreement was entered into on May 20, 2026, retroactively covering services since Mr. Markin's appointment as interim CEO on March 6, 2026.
• · The agreement can be terminated for cause by Cordoba Minerals or without cause by either party with one month's written notice.
• · Mr. Markin also serves as a director of Cordoba Minerals.

21-05-2026

Fourteen Puerto Rico closed-end funds announced a strategic review to pursue mergers with open-end funds to provide better liquidity and operational efficiencies. The boards are evaluating mergers that would allow daily redemptions at NAV, subject to shareholder approval and regulatory filings. If mergers are not approved, the boards will explore other alternatives to enhance liquidity.

• · The funds are unlisted closed-end funds registered under the Investment Company Act of 1940.
• · A merger would require shareholder approval and a registration statement on Form N-14.
• · If a merger is not approved, the board will examine other strategic alternatives to provide liquidity at or close to NAV.
• · The announcement was made on May 20, 2026, from San Juan, Puerto Rico.

21-05-2026

The Funds, a group of 14 Puerto Rico unlisted closed-end funds, announced a strategic review to pursue mergers with open-end funds to provide daily liquidity and operational efficiencies for shareholders. The Board of each Fund is evaluating the mergers, which would require shareholder approval, regulatory clearance, and final Board analysis. If shareholder approval is not obtained for a merger, the respective Board will examine other alternatives to enhance liquidity at or close to net asset value.

• · The merger evaluation is in an early stage — no registration statement has been filed yet; a surviving open-end fund would file Form N-14 subsequently.
• · If a merger is approved, shareholders of each target closed-end Fund would receive shares of the surviving open-end fund.
• · The announcement covers 14 separate Funds, each with its own Board conducting the evaluation.
• · The Funds currently have no direct path to liquidity for shareholders at NAV due to the closed-end structure.
• · Contact person: Patricia Duque at (787) 522-6776 for further information.

21-05-2026

Tax-Free Fixed Income Fund V for Puerto Rico Residents, Inc. and 13 other Puerto Rico closed-end funds announced a strategic review to pursue mergers with open-end funds to provide daily liquidity and operational efficiencies. The Boards are evaluating mergers subject to final analysis, regulatory approvals, and shareholder votes; if shareholder approval is not obtained, the Boards will examine other strategic alternatives to enhance liquidity at or near net asset value.

• · The announcement was made on May 20, 2026, from San Juan, Puerto Rico.
• · Each Fund is a Puerto Rico unlisted closed-end fund registered under the Investment Company Act of 1940.
• · The merger would require shareholder approval; if not obtained, the Board will examine other strategic alternatives to provide enhanced liquidity at or as close as possible to net asset value.
• · The surviving open-end fund would file a registration statement on Form N-14 with the SEC, including a proxy statement/prospectus.
• · Investors can obtain free copies of relevant documents on the SEC's website at www.sec.gov.

21-05-2026

The Board of Directors of 14 Puerto Rico closed-end funds, including Puerto Rico Residents Tax-Free Fund V, Inc., is evaluating a merger with an open-end fund to provide shareholders with daily liquidity at net asset value (NAV). Any merger would require shareholder approval, regulatory filings, and Board finalization; if a merger is not approved, the Board will examine other alternatives to enhance liquidity. The funds are currently pursuing this alternative to address the existing closed-end structure's lack of a direct redemption path.

• · The Board is conducting a thorough evaluation of a merger with an open-end fund, which would provide a direct path to liquidity via daily redemptions at NAV, unlike the current closed-end structure.
• · If a Fund cannot obtain required shareholder approval for a merger, its Board intends to examine other strategic alternatives to provide enhanced liquidity at or as close to NAV as possible.
• · The surviving open-end fund would file a registration statement on Form N-14 (including a proxy statement/prospectus) with the SEC; no securities offering will be made except by means of a prospectus meeting Section 10 of the Securities Act of 1933.
• · Investors are urged to read the joint proxy statement/prospectus and other documents when available, free of charge on the SEC’s website at www.sec.gov.

21-05-2026

Z Squared Inc. (formerly Coeptis Therapeutics Holdings, Inc.) announced a Phase 1 plan to reach 100 MW of AI-ready infrastructure capacity for inference workloads over the next 18 months. The company signed a binding letter of intent to acquire Skycore Digital, which operates approximately 24 MW of energized capacity in North Carolina with a potential expansion path to 42 MW. However, the company is operating from a 'virtually debt-free balance sheet' following its April 2026 Nasdaq listing, and there is no assurance that additional acquisition targets will be completed on acceptable terms or at all.

• · The company's common stock trades under the symbol ZSQR on the Nasdaq Global Market.
• · The company was formerly known as Coeptis Therapeutics Holdings, Inc. (name changed October 31, 2022) and before that Bull Horn Holdings Corp. (name changed November 15, 2018).
• · The company's current operations include crypto mining, which provides a foundation for newer verticals in power generation, data center development, and high-performance compute hosting.
• · The company manages a fleet of specialized computing hardware with in-house repair and lifecycle management programs.
• · The company's power strategy includes responding to curtailment schedules and seasonal electricity rate fluctuations to lower cost per kilowatt-hour.
• · The intended customers for Z Squared's AI-ready capacity are NeoCloud operators and AI infrastructure operators deploying production inference workloads.
• · Under the customer model, the customer brings compute hardware while Z Squared delivers power, cooling, density, fiber, security, and operations.
• · The company's distributed, facility-agnostic infrastructure spans North Carolina, South Carolina, and Iowa.
• · The filing is a Regulation FD Disclosure (Item 7.01) and the press release is furnished, not filed, for SEC purposes.

21-05-2026

Charlie's Holdings, Inc. raised $1.27 million through the sale of 6,350,000 shares of common stock at $0.20 per share on May 20, 2026. The offering consisted of $270,000 in cash and $1.0 million in debt forgiveness, with proceeds earmarked for working capital. The transaction was conducted as an unregistered sale under Section 4(a)(2) of the Securities Act.

• · The offering was completed on May 20, 2026.
• · The shares have a par value of $0.001 per share.
• · The subscription agreement is filed as Exhibit 10.1 to the 8-K.
• · The company is not an emerging growth company as defined under the Securities Act.

21-05-2026

Independent Bank Corp (IBCP) filed an S-4/A registration statement for its merger with HCB Financial Corp, dated March 18, 2026. The merger is expected to close in 2026, with HCB shareholders receiving Independent common stock. The filing includes detailed merger terms, representations, and covenants, but no specific financial figures or performance metrics are provided.

• · The merger agreement was dated March 18, 2026.
• · HCB does not anticipate holding an annual meeting in 2026 other than the one held on April 15, 2026.
• · Shareholder proposals for Independent must be submitted 60-90 days before the annual meeting anniversary.
• · Documents incorporated by reference include Independent's 2025 10-K, 2026 proxy, and several 8-Ks.
• · Request for documents must be made by June 10, 2026 to receive them before the special meeting.

21-05-2026

Advance Auto Parts reported Q1 2026 net sales of $2.6 billion (flat YoY) and comparable store sales growth of 3.5%, its strongest in five years, driven by mid-single-digit Pro growth and low-single-digit DIY growth. Adjusted operating income margin expanded 410 bps YoY to 3.8%, and adjusted diluted EPS improved to $0.77 from a loss of $(0.22) in Q1 2025. However, GAAP net income remained flat at $24 million, and the company reaffirmed its full-year 2026 guidance with comparable store sales growth of only 1.0% to 2.0%.

• · Q1 2026 SG&A expenses decreased to 42.5% of net sales from 48.0% in Q1 2025, driven by cycling of ~$37M in expenses from closed stores and stronger sales.
• · Q1 2026 GAAP operating income was $69M vs. an operating loss of $131M in Q1 2025.
• · Q1 2026 adjusted SG&A was 41.3% of net sales vs. 43.2% in Q1 2025.
• · Q1 2026 gross profit margin expansion was supported by product margin improvements and cycling of ~90 bps of atypical margin headwind from the store optimization program.
• · Cash and cash equivalents decreased to $2.956B from $3.123B at year-end 2025.
• · Net cash used in operating activities improved to -$19M from -$156M in Q1 2025.
• · The company declared a regular cash dividend of $0.25 per share payable July 24, 2026.
• · FY 2026 guidance includes store openings of 40-45 and market hub openings of 10-15.
• · FY 2026 adjusted diluted EPS guidance range is $2.40 to $3.10.
• · Pre-tax interest expense for FY 2026 is expected to be ~$210M and pre-tax interest income ~$80M.

21-05-2026

Mayville Engineering Company has announced an underwritten public offering of its common stock, with William Blair and Craig-Hallum acting as lead book-runners. Proceeds will be used to reduce borrowings under its senior secured revolving credit facility (including debt from the July 2025 Accu-fab acquisition), fund capital expenditures, and for general corporate purposes. The offering is subject to market conditions and includes a 30-day underwriter option for an additional 15% of shares.

• · MEC has 27 facilities across nine states; 22 are in use
• · Senior secured revolving credit facility matures June 28, 2028
• · Interest rate on the credit facility as of March 31, 2026 was 6.42%
• · Proceeds will partly repay debt from the Accu-fab acquisition completed July 2025
• · Shelf registration statement effective since May 20, 2024
• · Underwriters have a 30-day option to purchase up to an additional 15% of shares offered

21-05-2026

Advanced Drainage Systems reported Q4 FY2026 net sales of $676.8M, up 9.9% YoY, driven by the NDS acquisition and strong Allied product growth, though organic sales rose only 2.0%. Adjusted EBITDA increased 6.4% to $188.0M, but GAAP net income from continuing operations plunged 54.1% to $35.2M due to acquisition-related costs and restructuring expenses. For FY2026, net sales grew 5.0% to $3,050.4M, while adjusted EBITDA margin improved to 31.6% from 30.6%; however, GAAP net income declined 5.0% and the company issued a cautious FY2027 outlook citing geopolitical and economic uncertainty.

• · Q4 FY2026 Stormwater sales were $534.7M (up 11.7% YoY), including $48.8M from NDS; organic Stormwater growth was only 2%.
• · Q4 FY2026 Wastewater sales were $142.0M (up 3.7% YoY).
• · Q4 FY2026 gross profit margin was 35.1% ($237.7M) vs 36.7% ($226.3M) in prior year.
• · Q4 FY2026 SG&A expense surged 50.5% to $137.6M (20.3% of sales) from $91.4M (14.8% of sales), driven by NDS acquisition and transaction costs.
• · Q4 FY2026 income from operations fell 54.4% to $53.3M from $117.0M.
• · FY2026 Stormwater sales were $2,397.4M (up 3.1% YoY); Wastewater sales were $653.0M (up 13.0% YoY).
• · FY2026 gross profit margin was 38.3% ($1,167.4M) vs 37.7% ($1,094.2M) in prior year.
• · FY2026 SG&A expense increased 23.4% to $469.5M (15.4% of sales) from $380.4M (13.1% of sales).
• · FY2026 income from operations declined 5.8% to $619.2M from $657.4M.
• · FY2026 capital expenditures increased $36.8M over prior year.
• · Net debt rose $586.5M to $1,548.9M due to NDS acquisition financing.
• · Leverage ratio was 1.6x as of March 31, 2026.
• · FY2027 outlook: net sales $3.350B-$3.550B, Adjusted EBITDA $1.0B-$1.050B, capex ~$200M.
• · Company repurchased 0.7M shares for $99.2M in FY2026; $1.0B remains under authorization.
• · Higher-margin Infiltrator and Allied products grew 14% and 13% respectively in FY2026, representing 48% of total revenue.
• · Adjusted EBITDA margin in Q4 FY2026 declined to 27.8% from 28.7% in prior year.
• · Net loss from discontinued operations was $1.09M in Q4 and FY2026.

21-05-2026

D-Wave Quantum Inc. announced on May 21, 2026 that it has signed a Letter of Intent (LOI) for $100 million in proposed funding under the U.S. CHIPS and Science Act, administered by the U.S. Department of Commerce. The funding would accelerate the development and scaling of D-Wave's annealing and gate-model quantum systems across its R&D facilities in Boca Raton (FL), New Haven (CT), and Burnaby (BC, Canada). In exchange, D-Wave would issue $100 million in shares of common stock to the Department. The transaction remains subject to the execution of definitive award documents and carries risks including potential dilution to existing stockholders and uncertainty that the funding will be finalized.

• · The LOI is for proposed funding, not a final award; execution of definitive documents is required.
• · D-Wave would issue $100 million in shares of common stock to the Department as part of the transaction.
• · Facilities mentioned: Boca Raton (FL) R&D facility (forthcoming), New Haven (CT) R&D center, and Burnaby (BC, Canada) R&D center.
• · Risks highlighted: potential dilution to existing stockholders, possible suspension or termination of award negotiations, and dependence on availability of appropriated funds.

21-05-2026

Hemab Therapeutics reported Q1 2026 financial results with a net loss of $22.7M, up from $15.3M in Q1 2025, driven by increased R&D and G&A expenses. The company completed an upsized IPO in May 2026, raising gross proceeds of $346.7M, and received Breakthrough Therapy Designation for sutacimig in Glanzmann thrombasthenia. However, cash and equivalents decreased to $163.5M from $185.5M at year-end 2025, and operating cash burn widened to $21.6M from $13.0M in the prior year period.

• · Sutacimig received Orphan Drug Designation from both FDA and EMA for GT.
• · Phase 2 trial data for sutacimig in Factor VII deficiency expected late 2026 or early 2027.
• · Phase 1/2 trial data for HMB-002 in Von Willebrand Disease expected late 2026 or early 2027.
• · Total assets decreased to $175.3M as of March 31, 2026 from $194.8M at December 31, 2025.
• · Stockholders' deficit widened to $(198.6)M from $(176.6)M.
• · Net cash used in investing activities was $15.8M in Q1 2026 vs $6.0M in Q1 2025.
• · Net loss per share was $23.98 in Q1 2026 vs $16.18 in Q1 2025.

21-05-2026

S&P Global Inc. announced that its Board of Directors approved the separation of its Mobility division through a pro rata distribution of 100% of Mobility Global Inc. common stock to S&P Global shareholders. Shareholders will receive one share of Mobility Global for each S&P Global share held as of the June 15, 2026 record date, with the distribution expected to be effective on July 1, 2026. The separation is subject to customary conditions, including SEC effectiveness of Mobility Global's Form 10 registration statement.

• · The distribution ratio is one share of Mobility Global common stock for every one share of S&P Global common stock.
• · Record date for the distribution is June 15, 2026.
• · Distribution effective date is July 1, 2026 at 12:01 a.m. New York City time.
• · S&P Global will retain no ownership interest in Mobility Global after the separation.
• · Completion is subject to customary conditions, including SEC effectiveness of Mobility Global's Form 10 and no Board determination that proceeding is inadvisable.

21-05-2026

Badger Meter, Inc. filed an 8-K on May 21, 2026, to disclose a presentation used during its Investor Day. The filing is a Regulation FD disclosure and does not contain any financial results or quantitative data.

• · The presentation (Exhibit 99.1) was used during the Investor Day on May 21, 2026.
• · The information is furnished under Item 7.01 and is not deemed filed for Section 18 purposes.

21-05-2026

Universal Health Services, Inc. (UHS) announced the resignation of Matthew J. Peterson, Executive Vice President and President of Behavioral Health, effective June 19, 2026, to pursue an external non-competitive opportunity. All of his unvested equity awards will terminate, and he will receive no further compensation beyond accrued benefits. CEO Marc D. Miller will assume interim responsibilities for the Behavioral Health Division while a permanent replacement search begins.

• · Mr. Peterson has been with the company since 2019.
• · His resignation is effective June 19, 2026.
• · All unvested stock options, restricted stock units, and performance-based restricted stock units will terminate as of the effective date.
• · No severance or additional compensation beyond accrued benefits and legally required payments.
• · CEO Marc D. Miller will oversee the Behavioral Health Division with the help of Senior Vice Presidents during the interim period.

21-05-2026

PepGen Inc. furnished an updated Corporate Presentation on May 21, 2026, in connection with its participation in the 15th International Myotonic Dystrophy Consortium (May 26-30, 2026). The filing is a Regulation FD disclosure and does not contain any financial results or quantitative performance data.

• · The updated Corporate Presentation was furnished as Exhibit 99.1 and is incorporated by reference.
• · The presentation is being used at the 15th International Myotonic Dystrophy Consortium held May 26-30, 2026.
• · The information is furnished, not filed, under the Exchange Act and is not subject to Section 18 liabilities.

21-05-2026

Onto Innovation announced the pricing of an upsized private offering of $1.3 billion in 0.00% convertible senior notes due 2031, with an option for an additional $200 million. The company will use approximately $77.1 million for capped call transactions, $205 million to repurchase 0.8 million shares concurrently, and the remainder for general corporate purposes, including potential financing for the acquisition of 27% of Rigaku Holdings Corporation. The notes are zero-coupon and convertible at an initial conversion price of $381.80 per share, representing a 50% premium over the stock's closing price on May 18, 2026.

• · The notes are zero-coupon and do not accrete; they mature on June 1, 2031.
• · Noteholders can convert only upon certain events before March 1, 2031, and at any time after that until two trading days before maturity.
• · Onto Innovation will satisfy conversions by paying cash up to the principal amount and may pay cash, shares, or a combination for any excess.
• · The notes are not redeemable before June 6, 2029; after that, redemption is allowed only if the stock price exceeds 130% of the conversion price for a specified period.
• · Upon a fundamental change, noteholders can require repurchase at principal plus accrued interest.
• · The capped call transactions are designed to reduce potential dilution from conversion, with an initial cap price of $509.06 per share.
• · Option counterparties may engage in hedging activities that could affect the stock price and conversion value.
• · The concurrent share repurchase of $205 million may have increased the stock price, resulting in a higher initial conversion price.
• · The notes and any conversion shares are not registered under the Securities Act and are offered only to qualified institutional buyers.

21-05-2026

Raab & Moskowitz Asset Management LLC filed its Form 13F-HR for the quarter ended March 31, 2026, reporting a total of 187 equity holdings with an aggregate market value of approximately $449.6 million. The portfolio is heavily weighted toward large-cap ETFs and blue-chip stocks, with top positions including Vanguard Total Stock Market ETF ($21.7M), Apple Inc. ($20.1M), Berkshire Hathaway ($11.9M), and Invesco S&P 500 Equal Weight ETF ($11.2M). The filing reflects a diversified, value-oriented strategy with significant exposure to healthcare, technology, and consumer staples, though no prior-period comparison is available to assess changes in holdings.

• · All 187 holdings are reported as sole voting and dispositive power, indicating no shared or non-discretionary accounts.
• · The largest single equity position by market value is Vanguard Total Stock Market ETF at $21.7 million, followed by Apple Inc. at $20.1 million.
• · The largest position by share count is Pfizer Inc. with 232,244 shares, valued at $6.5 million.
• · The portfolio includes significant ETF exposure: Schwab US Dividend Equity ETF (146,815 shares), Vanguard Whitehall High Dividend Yield ETF (88,643 shares), and iShares Select Dividend ETF (74,238 shares).
• · No options, warrants, or convertible securities are reported; all positions are common stocks or ETFs.
• · The filing was signed by Daniel H. Moskowitz, Member and Chief Compliance Officer, on May 21, 2026.

21-05-2026

NovoCure Ltd filed definitive additional proxy materials (DEFA14A) on May 21, 2026, related to its upcoming shareholder meeting. The filing does not contain financial results or operational data, but serves as a solicitation update for shareholder voting matters.

• · Filing is a definitive additional proxy material (DEFA14A), not a preliminary or definitive proxy statement.
• · No fee was required for this filing.
• · The filing is related to soliciting shareholder votes for the 2026 annual meeting.

21-05-2026

Unity Bancorp, Inc. declared a cash dividend of $0.16 per common share, payable on June 18, 2026, to shareholders of record as of June 4, 2026. The announcement was made via a press release on May 21, 2026, and filed as an 8-K. No prior-period dividend data is provided, so no period-over-period comparison is available.

• · Dividend record date: June 4, 2026
• · Dividend payment date: June 18, 2026
• · Press release filed as Exhibit 99.1

21-05-2026

California Water Service Group (CWT) held its Annual Meeting of Stockholders on May 20, 2026. All 11 director nominees were elected, the advisory vote on executive compensation was approved, and the appointment of Deloitte & Touche LLP as independent auditor for 2025 was ratified. Note that while the auditor ratification received broad support (over 98% of votes cast for), a significant minority of approximately 5.1% of votes cast were against the say-on-pay proposal, and certain directors (e.g., Thomas M. Krummel, M.D. and Martin A. Kropelnicki) received notably higher against votes than others.

• · Total shares outstanding voting context: broker non-votes of 4,633,226 on all director elections and on say-on-pay proposal, no broker non-votes on auditor ratification.
• · Director with highest vote total: Patricia K. Wagner (49,524,465 for, 96,420 against).
• · Director with highest against vote count: Thomas M. Krummel, M.D. (2,122,312 against, the highest against for any director).
• · Auditor ratification received 53,131,825 votes for, 1,077,647 against, and 132,238 abstentions, indicating strong shareholder support.
• · The say-on-pay proposal had 46,971,099 votes for, 2,539,067 against, and 198,318 abstentions.

21-05-2026

Direct Digital Holdings, Inc. filed an 8-K to recast portions of its 2025 Form 10-K, reflecting a change in reportable segments from two (buy-side and sell-side) to one consolidated segment (digital advertising), effective Q1 2026, and a 4-to-1 reverse stock split executed on April 27, 2026. The company also unified its buy-side businesses (Orange 142 and Huddled Masses) in October 2024 and launched a new product, Ignition+, in early 2026. No new financial results or performance metrics are provided in this filing.

• · Reverse stock split was 4-to-1, effective April 27, 2026, affecting both Series A and Series B common stock.
• · The company changed from two reportable segments (buy-side and sell-side) to one consolidated segment (digital advertising) effective Q1 2026.
• · Colossus SSP processed over 170 billion average monthly impressions and served approximately 174,000 buyers/advertisers in 2025.
• · The buy-side business (Orange 142) has been in operation since 2013; Colossus Media since 2017.
• · The company completed its IPO in February 2022.
• · The filing does not update any financial results or provide new performance data beyond segment and stock split recasting.

21-05-2026

ParkerVision announced the appointment of Anthony (Tony) Bowers as a Class II director, filling the vacancy created by the retirement of Lewis H. Titterton, Jr. on May 15, 2026. Mr. Bowers brings over 30 years of corporate and institutional sales experience, including leadership roles at OTR Global and Goldman Sachs, and will support the company's international licensing program and patent enforcement strategy.

• · The vacancy was created by the May 15, 2026 retirement of Lewis H. Titterton, Jr.
• · Mr. Titterton remains a large shareholder and is expected to continue supporting the company.
• · Mr. Bowers holds an MBA in Accounting and Finance from Wharton School and a BA in Economics from Amherst College.
• · ParkerVision is involved in multiple U.S. patent enforcement actions alleging broad infringement.
• · The company's forward-looking statements carry standard risks including those detailed in its 10-K for FY2025 and 10-Q for Q1 2026.

21-05-2026

Ecovyst Inc. held its 2026 Annual Meeting on May 20, 2026, with 100,214,085 shares represented (91.6% of 109,450,306 outstanding). All five Class I director nominees were elected, the say-on-pay proposal was approved on an advisory basis, and the appointment of PricewaterhouseCoopers LLP as auditor for fiscal 2026 was ratified. All proposals passed with strong support, though broker non-votes accounted for 6,234,425 shares on the director elections and say-on-pay.

• · All director nominees received over 93 million votes for, with the lowest being David A. Bradley at 93,243,708.
• · Say-on-pay proposal received 93,076,499 votes for, 870,548 against, and 32,613 abstentions.
• · Auditor ratification received 100,146,577 votes for, 61,486 against, and 6,022 abstentions, with no broker non-votes.
• · The definitive proxy statement was filed on April 15, 2026.

21-05-2026

Baker Hughes Company announced that it has filed a Form CO with the European Commission to initiate the Phase I review period for its pending acquisition of Chart Industries, Inc. The company expects the merger to close in July 2026, subject to EC approval, other regulatory approvals, and customary closing conditions.

• · The Merger Agreement was entered into on July 28, 2025.
• · Baker Hughes and Chart concluded their pre-notification process with the European Commission before the Form CO filing.
• · The Phase I review period follows prescribed timelines under EC regulations.